The authors concluded that PET-MRI is able to detect biochemically recurrent PCa at least as accurately as PET-CT for local recurrence, lymph node metastasis and distant metastasis, while the substitution of PET-CT by PET-MRI adds sensitivity in PSMA lesion detection also in the setting of distant recurrence due to both the MR and TOF PET components [26]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.